STOP, LOOK, LISTEN !!! As always, do your own research before purchase and be cautious.
BioNeutral Announces 100% Total Kill of Swine Flu (H1N1) on Virtual Contact of This Pandemic Causing Virus in an Independent Lab Test Using Its Ygiene(TM) Hospital Grade AntimicrobialFont size: A | A | A8:30 AM ET 8/18/09 | BusinessWire RELATED QUOTES
11:13 AM ET 8/18/09 Symbol Last % Chg BONU 0.40 53.85% Real time quote.
BioNeutral Group, Inc. ("BioNeutral") (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced today that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia demonstrated that Ygiene(TM) Hospital Grade Antimicrobial totally eradicated the H1N1 Swine Flu virus in 20 seconds (Virtual Contact). This independent testing shows that Ygiene(TM) Hospital Grade Antimicrobial is extremely effective against the Swine Flu. BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial is also one of a few antimicrobials actually tested against the specific H1N1 Swine Flu Virus.
On June 11th the World Health Organization (WHO) declared that the original outbreak of Swine Flu (H1N1) had progressed unabated to a global pandemic Level 6, meaning that isolation and control of human to human infection within a single nation or global region was not possible. Current concerns with the Swine Flu are that it may return to North America this fall in an even more resilient viral form. While many current commercial antimicrobials are believed to be effective against the Swine Flu Virus, only a handful have actually been tested against the H1N1 (Swine Flu) Virus. If the Swine Flu Virus reappears in a more resilient mutated viral form, the likelihood increases that the untested antimicrobials currently on the market may not be effective against this virus. In addition, many of today's commercial antimicrobials require an extremely long contact time of 10 minutes to be effective against the flu virus. In contrast, the Ygiene(TM) Hospital Grade Antimicrobial, developed by BioNeutral, requires only 20 seconds of contact time, making cleaning and elimination of the virus more realistic in today's world where speed is of the essence. The speed of BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial will meet these time to kill demands.
Recently, former Secretary of Homeland Security, Michael Chertoff and Dr. J. Bennet Waters wrote an article about the problems and issues associated with a pandemic. In the article (chertoffgroup.com) they explain that using old conventional thinking and "treating a pandemic as a health problem is not just bad policy, it is a dangerous approach." Associated with a pandemic are a myriad of diplomatic, economic and national security consequences along with complex operational issues at all levels, in all sectors. Plans to deal with a pandemic must include prevention, detection, response and recovery. BioNeutral believes that its Ygiene(TM) Hospital Grade Antimicrobial will be an integral part of a comprehensive plan that deals with a pandemic such as the Swine Flu.
BioNeutral Group CEO, Stephen J. Browand, stated "Ygiene is an inexpensive, Green to the environment, non corrosive, non-staining, mild to the touch chemical formulation, which out performs all other antimicrobials and will become the solution of choice once approved by the EPA for commercialization in the United States. The company is in discussions to distribute and license its groundbreaking technology which includes a family of formulations that are all sporicidal."
Chief Scientist at BioNeutral Group, Dr. Andy Kielbania stated "These independent lab results continue to verify the exceptional efficacy and speed to kill of our Ygiene(TM) Hospital Grade Antimicrobial. In addition, our strategy of raising the bar on antimicrobial performance includes actually testing against the microorganisms where we intend to make our EPA claims. We prefer not to make claims by extrapolating scientific data since this approach may lead to invalid conclusions." He continued, "We also believe for an antimicrobial to be effective it must eradicate quickly like the 20 seconds demonstrated by our Ygiene(TM) Hospital Grade. Based upon all the independent testing results obtained to date on our Ygiene(TM) antimicrobial, we believe it will also be extremely effective and have a beneficial toxicity profile and a significant cost performance advantage when used in a diluted form against the H1N1 virus. We are currently pursuing this approach. The 10 minute required contact time claimed by many of today's commercial disinfectants is much too long since those individuals responsible for cleaning areas may not rigorously follow these extended time requirements. Developing our world class antimicrobials with rapid kill times is an important part of our strategy of raising the bar on today's antimicrobial performance."
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
Microbiotest Inc. located in Sterling Virginia is a world recognized laboratory with over 20 years of experience in testing a broad spectrum of microbiological materials. Microbiotest effectively collaborates and has an excellent track record with its clients that are developing new products to meet various Agency regulatory requirements using recognized protocols both in North America and abroad. In addition Microbiotest has the ability to design unique tests for special situations.
Forward-Looking Statements
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
SOURCE: BioNeutral Group, Inc.
BioNeutral Group Inc. Stephen J. Browand, President and CEO steve*bioneutralgroup.com or Investor Relations Aimee Boutcher, 973-239-2878 aboutcher*aol.com
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
I`m in - thanks for the post, and the news!
-------------------- Please buy responsibly. Do not take my word on any stock. Do your own research. Thanks & good luck! Posts: 439 | From: USA | Registered: Jul 2009
| IP: Logged |
BioNeutral's Consumer Grade Ygiene(TM) Delivers a 100% Total Kill on Contact of Swine Flu (H1N1) Virus
- For the HomeLast update: 8/20/2009 8:30:03 AMNEWARK, N.J., Aug 20, 2009 (BUSINESS WIRE) -- BioNeutral Group, Inc. ("BioNeutral") (BONU), a specialty chemical technology based Life Science Company, announced today that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia demonstrated that Ygiene(TM) Consumer Grade Antimicrobial (A significantly milder and diluted variation of the Ygiene(TM) Hospital Grade Formulation) totally eradicated the H1N1 Swine Flu Virus in 20 seconds (Virtually on Contact). This independent testing shows that Ygiene(TM) Consumer Grade Antimicrobial equaled the performance of our hospital grade formultaion and is extremely effective against the Swine Flu. It is one of a few antimicrobials actually tested against the specific H1N1 Swine Flu Virus. Commerce Secretary Gary Locke stated, concerning the H1N1 Virus, "Its more than just a significant health issue. It has the potential to affect every aspect of our lives," Locke said. "It will take Americans from every walk of life pulling together and doing our part to mount an effective response." As the first pandemic in more than 40 years, it has the potential to cause massive disruptions for businesses, schools and governments. The United States and other northern nations have been scrambling to prepare for a resurgence of the virus The virus, which first surfaced last spring in Mexico, has spread to at least 168 countries and sickened 177,000. It has contributed to at least 1,462 deaths, including 477 in the United States, and is still circulating in the population. "We are well on our way to achieving our objective to have the fastest acting, least expensive, longest lasting, simple to use, green formulations to eliminate swine flu from home, office, schools and public gathering places," said Dr. Andy Kielbania, chief scientist for Bioneutral Group Inc. "This mild formulation can come into daily contact with skin and clothing providing added protection against H1N1 and other dangerous organisms for the general population and the broader health care sector, as well." These independent lab test results demonstrate that BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial will deliver the same speed and efficacy for eradicating the Swine Flu virus as BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial which is designed to eliminate very difficult to kill dangerous organisms in the hospital environment responsible for nosocomial infections. BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial will provide household consumers the peace of mind knowing that it will be able to totally eliminate the Swine Flu virus in 20 seconds, virtually on contact, while still being environmentally friendly and gentle to surfaces being cleaned in the home. BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial will contribute to maintaining good family health. This 20 second kill time is also much faster than the 10 minute kill time claimed by many of today's commercially available household disinfectants. BioNeutral Group Inc. CEO, Stephen J. Browand, stated, "BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial is an important addition to the company's growing list of formulations which will be presented to the EPA for regulatory approval." About BioNeutral Group, Inc. Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. More information about the Company may be found at About Microbiotest Inc. Microbiotest Inc. located in Sterling Virginia is a world recognized laboratory with over 20 years of experience in testing a broad spectrum of microbiological materials. Microbiotest effectively collaborates and has an excellent track record with its clients that are developing new products to meet various Agency regulatory requirements using recognized protocols both in North America and abroad. In addition Microbiotest has the ability to design unique tests for special situations. Forward-Looking Statements BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States. SOURCE: BioNeutral Group, Inc. BioNeutral Group Inc. Stephen J. Browand, President and CEO steve*bioneutralgroup.com or Investor Relations Aimee Boutcher, 973-239-2878 aboutcher*aol.comCopyright Business Wire 2009
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
IT'S RISING AS EXPECTED SLOWLY, BUT STEADILY. OPENED AT 0.50 TODAY, NOW IT'S AT 0.59. THE HIGH SOFAR TODAY WAS 0.62
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
.70 now. Will we hit $1.00 today? I lowered my sell order from $1.29 to .73 this morning - but just raised it back up to $1.30 for now!
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
I would hope so if not over. you never know of a company that has a cure for swine flu thesedays. It rising faster that I was not able to keep up with the asking price when I tried to get more shares. Right now, it's at 0.78. This may turn out to be another HGSI.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
What's your sell price? You saw the headlines this morning about possibly 90,000 people in U.S. dying this fall from swine flu - HALF the country could catch it? 2 Miami Dolphins players have it now - and those guys are in great shape - so it can take down anybody.
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
Swine Flu Could Cause 90,000 US DeathsCNN posted: 5 HOURS 19 MINUTES AGOcomments: 363filed under: Health News, National News PRINT|E-MAILMOREText SizeAAAWASHINGTON (Aug. 24) -- The H1N1 flu virus could cause up to 90,000 U.S. deaths, mainly among children and young adults, if it resurges this fall as expected, according to a report released Monday by a presidential advisory panel. The H1N1 virus, commonly known as swine flu virus, could infect between 30 percent and 50 percent of the American population during the fall and winter and lead to as many as 1.8 million U.S. hospital admissions, the President's Council of Advisors on Science and Technology reported. Skip over this content
posted
Love The Market, Thank you for the posting. I saw this information on CNN news last evening and that is why I alerted everyone to watch this stock today along with HTSD. In fact acording to folks at the trading dexk,BONU has ran tremendously well this first run. The second run for today is almost on the way....imo. This is another chance to get in as it has mellowed a a beat from the 0.80 high today with the current 0.70 asking. Some folks may say that it still to high a price, but there again, remember HGSI, although that is a different staock. I am still watching it.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
This was published before CNN's news on Swine Flu. I guess for what it's worth anyone can draw some conclusion as to what BONU's potential is around the world.
BioNeutral Group Hosts Discussions with Four of the World's Largest Health Care Companies 8:30 AM ET 8/24/09 | BusinessWire BioNeutral Group, Inc. ("BioNeutral") (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced discussions with four of the world's largest health care companies. The discussions included both scientific and business representatives all interested in BioNeutral's game changing technology - "Sporicidal performance on surfaces and skin." Game changing technology is an infrequent occurrence. However, it is easy to identify and differentiate from the run of the mill or obsolete technology and thus generates intense interest. BioNeutral is in a unique position in that it has not solicited contacts with major players in the antimicrobial and health care arena; instead these well known companies have been contacting BioNeutral to develop partnering relationships.
Any antimicrobial which is not sporicidal may be a carrier for the dangerous and difficult to kill organisms which may then be transported from person to person (this includes all known alcohol, silver or quat based formulations). For example, Clostridium Difficile spores are associated with hospital acquired infections which results in diverted heath care provider's efforts, millions of dollars in extra expenses and hundreds of thousands of unnecessary deaths annually in the US alone. The best high powered currently used hospital disinfectants based upon quaternary ammonium compounds, silver based disinfectants or alcohol washes are totally ineffective at eradicating Clostridium Difficile (C-diff) spores, resulting in a serious unmet need in the health care arena. BioNeutral's Ygiene(TM) is the clear solution for this serious problem.
Dr. Andy Kielbania, Chief Scientist at BioNeutral Group stated, "Results of in-house testing conducted this past week demonstrated a 30 second kill time for the most difficult to kill spores with a mild formulation that is gentle to skin, surfaces and fabric. These are the best results we have produced thus far."
"When these results are confirmed by independent testing," said one of the health care executives, "It represents a game changer which will determine control of a worldwide antimicrobial health care market."
BioNeutral Group Inc. CEO, Stephen J. Browand, stated, "If game changing technology were presently out there, we would not be inundated with calls from the major players in the healthcare field. Killing low level microorganisms with old, me too technology (alcohol, silver, quats or bleach) has been available for quite some time. Rapidily eliminating dangerous spores such as Clostridium Difficile (C-diff) with our new mild Ygiene(TM) formulation which can be exposed to skin is considered the holy grail of antimicrobial performance. Independent lab testing confirming last week's R&D breakthrough should take approximately three weeks".
BioNeutral Group Inc. has confirmed independent test results which indisputably show the Company's Ygiene(TM) formulations outperform virtually all antimicrobials available when it comes to difficult to kill, dangerous organisms including black mold. Dissimilar to silver, bleach and quat based older technology; BioNeutral's Ygiene(TM) is non corrosive, non-staining, non flammable and completely sporicidal.
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and Chemo Neutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
SOURCE: BioNeutral Group, Inc.
BioNeutral Group Inc. Stephen J. Browand, President and CEO steve*bioneutralgroup.com or Investor Relations Aimee Boutcher, 973 239-2878 aboutcher*aol.com
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
Dagny, did you get in on this one when I first posted it ? I guess you may have doubled your money or tripled, if you took advantage of yesterday's ride with BONU.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
BioNeutral Group, Inc. Hires The Investor Relations Group BioNeutral Group, Inc. Hires The Investor Relations Group Aug. 26, 2009 (Business Wire) -- BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU - News), a specialty chemical technology based life science company, has hired the Investor Relations Group (“IRG”), a thirteen-year-old corporate communications firm based in New York City, to serve as its investor relations and public relations agency.
IRG’s investor relations team will implement competitive analysis strategies and its proprietary database of portfolio managers and equity analysts in the global investment community to increase awareness of BioNeutral’s status as an innovator in the antimicrobial industry. The program will include pre-qualified one-on-one introductions, traditional outreach practices, and strategic advisement. Concurrent with that effort, the public relations team will initiate an outreach campaign targeting editors, writers, and segment producers of local and national trade and consumer online, print, radio, and broadcast media outlets.
IRG’s corporate communications program includes new media and multimedia initiatives that involve the creation of broadcast-ready corporate videos, podcasts, and the creation of social networking, video service, and micro-****ging accounts. The Investor Relations Group was recently honored with a “Stevie Award” for Investor Relations Program of the Year and named a finalist in the Best Media Website category from the 2009 American Business Awards.
“BioNeutral is nearing the registration of our lead Ygiene™ product technology with the EPA,” said Stephen J. Browand, the company’s President and Chief Executive Officer. “This is a very significant milestone in the company’s history and we feel that IRG has the expertise and industry relationships necessary to help us meet our objectives, gain exposure, and ultimately raise our corporate profile. BioNeutral is a unique company with products that have many technical advantages over existing, better-known items currently on the market. We have every confidence in IRG’s ability to successfully communicate our story with the investment community, our shareholders, the media, and the public-at-large.”
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
BioNeutral's Ygiene(TM) Kills Dangerous MRSA in Seconds BioNeutral's Ygiene(TM) Kills Dangerous MRSA in Seconds Aug. 27, 2009 (Business Wire) -- BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based life science company, reports that its Ygiene™ Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. The required EPA testing procedures occurred at ATS Labs.
MRSA, or Methicillin-resistant Staphylococcus aureus, is a very serious health threatening microorganisms present in many health care facilities and community environments. MRSA is one of the more serious antibiotic resistant heath threatening microorganisms that contributes to Hospital Acquired Infections (HAI’s). In the U.S. alone, over two million people annually are afflicted with Hospital Acquired Infections with approximately one hundred thousand people dying. Worldwide Hospital Acquired Infections are on the rise and will lead to hundreds of thousands needless deaths annually. MRSA is also becoming a serious issue associated with Community Acquired Infections such as school and campus settings. With its power to rapidly and totally eliminate MRSA in less than one minute, BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will be a significant part of the future solution for controlling Hospital Acquired Infections and Community Acquired Infections.
“These independent ATS Labs test results completely validate our internal product development efforts,” said BioNeutral Chief Scientist for BioNeutral, Dr. Andrew Kielbania. “The level of efficacy demonstrated in these independent tests is exceptional. Passing this difficult EPA required test for the elimination of MRSA is consistent with the ability of our Ygiene™ Hospital Grade Antimicrobial to address a very serious unmet need associated with Hospital Acquired Infections in the health care area. We believe our Ygiene™ Hospital Grade Antimicrobial will contribute to the saving of many lives in addition to resources at health care facilities.”
“We often use independent labs to support our in-house work, and are very pleased with these test results,” said Stephen Browand, CEO at BioNeutral. “We use tests that demand exceptional performance from our antimicrobial products. Current disinfectants on the market are clearly not doing the job when it comes to controlling HAIs; we believe that our antimicrobial products will help remedy that unacceptable situation. Given these impressive results, we have every confidence that our Ygiene Hospital Grade Antimicrobial will have a major impact in reducing Hospital Acquired Infections and saving lives while protecting the environment.”
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
I got out at $1.04. When it shades some, I'll buy back. I was a very fun ride, although the ride is not over yet.....
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
geezes.... i left for an hour... wished i woulda saw it go over 1.10 i def woulda sold out lol... Good job all.... Love the Market did you sell out?
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
lol oldseven... Never know... It's done nothing but go up with minimal retrace... Most indicators do show "overbought." Unless the product is just that good and this thing will just keep on rocketing...
Check this out... Looks like their new IR team has started Pretty sure this wasn't up there yesterday... or maybe two days ago.
EDIT: ouch... The IR contact info must not be created yet. I received a failure to deliver notice. I have been trying to get them to answer some questions for over a week in a half now...
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
With FLU season just about to start, I do not see this going down that low(.70). If you think it will go that low, why not short it? I think it will go up over the next couple months along with the vaccination stock and whoever makes the masks. Anyone know of who's these might be?
-------------------- Only ONE good stock away from retirement! Posts: 493 | Registered: May 2009
| IP: Logged |
posted
Hey now hey now oldseven I didn't say it'd go to .70 love posted that when it was trading for around .81
As I said in an earlier post *if* it hit 1.10 i'm out... and well... she hit 1.10 again so I'm out... I'll be watching for a dip tho GL all!!!
Posts: 68 | From: The world | Registered: Aug 2009
| IP: Logged |
posted
Duck - be glad you didn't sell! It closed at $1.18! I was taken out for 4200 at $1.03 and actually got $1.04 for 800 shares on a $1.03 limit order - so it must have been FLYING. I said $1.03 by lunch and I was taken out at 11am!
I made $3,150 on it and was only in less than a week at .43 - Funny (but NOT) I had a buy in yesterday for another 2500 at .70 and CANCELED it at about 3pm to try and buy something else. Didn't get it - BUT BONU dropped to .68 before closing at .73 - so I would have made another $625 and ALMOST woould be recovered from by Eddie Bauer and BHWF losses. Imagine that - I've had 2 doubles and a double 'n a half-er, and I'm still down big over the years - but I've made more in the past 2 months than the past 6 years!
I wish I didn't change my sell down from $1.29 the other day - I put a new order in to buy 8000 at .80 - but it may not drop that low for a bit -This COULD be a $10 stock THIS year, imho. But who knows.....
Good luck!
Posts: 2793 | From: Coral Springs, FL, USA | Registered: Aug 2003
| IP: Logged |
posted
I agree ! How I wish I did not get out. Still waiting for a dip to get in , but I am not sure of any dip today.
Posts: 602 | From: Minneapolis | Registered: Jul 2009
| IP: Logged |
posted
I've got a feeling this will see NASDAQ before we get a dip back below $1.00 Damn..... of all the stocks to sell too soon - and we really had no reason to - except that you'd think the way that it way shooting through the sky that it was bound to fall back to earth hard! But it's up in the stratosphere now. Over $1.00 increase in a week! Damn.... Now I sound like a hog - I'll TRY to be a happy little pig instead! CONGRATS to us all and may all our picks be like this one!
Now this from the ihub board:
Skymark Research Initiates Independent Research Coverage On BioNeutral Group, Inc. Friday 08/28/2009 9:47 AM ET - Globenewswire
Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on BioNeutral Group, Inc. (OTCBB:BONU). Skymark Research is currently offering a complimentary trial subscription. To view our research go to: www.skymarkresearch.com
About SMR:
Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.skymarkresearch.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.skymarkresearch.com/signup.php
About BioNeutral Group, Inc. (OTCBB:BONU):
BioNeutral Group, Inc. (OTCBB:BONU) is headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey. BioNeutral Group, Inc. is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(tm) and Ogiene(tm), which are eco-friendly and include natural and common ingredients which are found in baby products and in everyday foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
SMR Disclosure:
Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, www.skymarkresearch.com, for complete risks and disclosures.
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Smile]](smile.gif)
![[Were Up]](graemlins/wereup.gif)
![[Wink]](wink.gif)
Pretty sure this wasn't up there yesterday... or maybe two days ago.![[Big Grin]](biggrin.gif)
I didn't say it'd go to .70 
